Biotech Values

[DewDiligence]

So do I take it that your assigned probabilities to a Roche or Amgen deal is nil or close to?

That’s too strong a statement, IMO. Roche and AMGN are possible FoB partners but neither has expressed an interest in the FoB arena, so I rank them below PFE, SNY, MRK, and NVS in terms of probability.